B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Glutamate Neurotransmitter Release Cycle

REACTOME PATHWAY
Reactome: R-HSA-2105004 genes34 compounds

The Glutamate Neurotransmitter Release Cycle pathway (Reactome ID: R-HSA-210500) involves 4 genes and is affected by 34 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

GLSSLC1A1SLC1A2SLC1A3

Compounds Affecting Glutamate Neurotransmitter Release Cycle

#CompoundTargets HitStudies
1Aspartic Acid300
2Glutamic Acid297
3Glutamic Acid300
4caffeic acid300
5myricetin-3-O-galactopyranoside [Supplementary Concept]300
6Resveratrol298
72-Methoxyestradiol300
8ag49014
9alpha-Linolenic Acid300
10Ampicillin Semi-synthetic derivative of penicillin that functions as294
11Calcimycin216
12cefaclor299
13cefatrizine114
14Cefixime300
15daph2
16Diazooxonorleucine32
17Disulfiram297
18Physostigmine300
19ethopropazine17
20Fenoterol300
21hydroxyindoleacetic acid300
22Hydroxyurea300
23Metaproterenol298
24methoxyhydroxyphenylglycol64
25Normetanephrine300
26Oxytetracycline300
27Physostigmine299
28piceatannol300
29Reserpine297
30Rotenone300
31Suramin300
32Tolazamide169
33tyrphostin 92
34D-Aspartic Acid29

About the Glutamate Neurotransmitter Release Cycle Pathway

The Glutamate Neurotransmitter Release Cycle pathway is catalogued in Reactome (ID: R-HSA-210500) and involves 4 genes. In the BiohacksAI corpus, 34 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include GLS, SLC1A1, SLC1A2, SLC1A3.